Summary: Garofalo Health Care S.p.A.

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Highlights: Garofalo Health Care S.p.A.

  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses: Garofalo Health Care S.p.A.

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company is in debt and has limited leeway for investment
  • The group usually releases earnings worse than estimated.

Ratings Chart: Garofalo Health Care S.p.A.

Source: Surperformance

Fundamentals (Composite) Global Valuation (Composite) Financial estimates revisions (Composite) Capi.($)
- 513M
15.36B
14.21B
12.01B
11.73B
9.84B
8.76B
7.53B
6.58B
5.35B
Average 9.19B
Weighted average by Cap.
See all sector ratings
Investor (Composite)
-
Trader (Composite)
ESG MSCI
-

Financials

Revenue growth
EPS growth
Capital Efficiency (Composite)
-
Net Margin
Financial Health (Composite)
-

Valuation

P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
-

Revisions

Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)

Business Predictability

Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
-
Financial estimates divergence
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. GHC Stock
  4. Ratings Garofalo Health Care S.p.A.